Dr. Joseph James Jennings, MD

Dr. Jennings practices at MedStar Health Surgery Center at Lafayette Centre in Washington, District of Columbia.

Dr. Jennings' NPI, 1538435714, was assigned on April 1, 2012. Dr. Jennings graduated from Georgetown University School Of Medicine in 2012. Dr. Jennings holds District of Columbia license MD042557.

Dr. Jennings' primary practice is MedStar Health Surgery Center at Lafayette Centre, at 1133 21st Street Nw Suite 1000, Washington, DC 20036. The practice phone is (202) 223-9040.

Dr. Jennings' primary practice is MedStar Health Surgery Center at Lafayette Centre in Washington, District of Columbia. Dr. Jennings is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Jennings to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jennings practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Jennings' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Jennings is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Jennings' licenses on file in 2 states: District of Columbia and Virginia.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic anemia, chronic inflammatory bowel disease (IBD), gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal or bowel obstruction among the conditions Dr. Jennings treats.

CMS data shows 589 Medicare services from Dr. Jennings across 12 procedure codes in 2024, for 358 Medicare patients. Medicare paid $71,235 for them.

CMS counts 358 Medicare patients who saw Dr. Jennings in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jennings' median patient age at 58, with 54% women.

In 2024, Dr. Jennings wrote 207 Medicare Part D claims for 92 patients. 71% of them were for generic drugs. CMS names the drug for 110 of them, across 7 drugs with 11 or more claims each, at $38,152 in total drug cost. In 2023, CMS named 89 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Jennings for performance year 2024, reported as part of a group. Dr. Jennings accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jennings as offering telehealth. CMS counts 100 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Jennings, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Jennings, published from 2018 to 2022. 2018 was the busiest year, with 4. The most frequent topics are Gastrointestinal Agents and Antibodies, Monoclonal, Humanized. Dr. Jennings has published most often in ACG Case Rep J. Dr. Jennings' most frequent co-authors are Dana Alsaadi, MD, Michele Barnhill and Andrew C. Caruso, MD.

CMS Open Payments shows 14 general payments to Dr. Jennings from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Samsung Bioepis Co., Ltd. paid the most, $400. It also lists 1 research payment totaling $500 in 2023.

Dmand AI lists 2 awards for Dr. Jennings, most recently First Place - Resident Clinical Vignette Presentation in 2014.

Dr. Jennings graduated from Georgetown University School Of Medicine in 2012. Dr. Jennings is a member of ACG, ACP, AMA, ASGE and SHM.

Dr. Jennings is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.